148 related articles for article (PubMed ID: 25448553)
1. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
Grabowski N; Hillaireau H; Vergnaud J; Tsapis N; Pallardy M; Kerdine-Römer S; Fattal E
Int J Pharm; 2015 Mar; 482(1-2):75-83. PubMed ID: 25448553
[TBL] [Abstract][Full Text] [Related]
2. Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles.
Aragao-Santiago L; Hillaireau H; Grabowski N; Mura S; Nascimento TL; Dufort S; Coll JL; Tsapis N; Fattal E
Nanotoxicology; 2016; 10(3):292-302. PubMed ID: 26573338
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells.
Grabowski N; Hillaireau H; Vergnaud J; Santiago LA; Kerdine-Romer S; Pallardy M; Tsapis N; Fattal E
Int J Pharm; 2013 Oct; 454(2):686-94. PubMed ID: 23747506
[TBL] [Abstract][Full Text] [Related]
4. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells.
Mura S; Hillaireau H; Nicolas J; Le Droumaguet B; Gueutin C; Zanna S; Tsapis N; Fattal E
Int J Nanomedicine; 2011; 6():2591-605. PubMed ID: 22114491
[TBL] [Abstract][Full Text] [Related]
5. Surface-Modified Biodegradable Nanoparticles' Impact on Cytotoxicity and Inflammation Response on a Co-Culture of Lung Epithelial Cells and Human-Like Macrophages.
Grabowski N; Hillaireau H; Vergnaud-Gauduchon J; Nicolas V; Tsapis N; Kerdine-Römer S; Fattal E
J Biomed Nanotechnol; 2016 Jan; 12(1):135-46. PubMed ID: 27301179
[TBL] [Abstract][Full Text] [Related]
6. Microspheres prepared with different co-polymers of poly(lactic-glycolic acid) (PLGA) or with chitosan cause distinct effects on macrophages.
Bitencourt Cda S; Silva LB; Pereira PA; Gelfuso GM; Faccioli LH
Colloids Surf B Biointerfaces; 2015 Dec; 136():678-86. PubMed ID: 26497115
[TBL] [Abstract][Full Text] [Related]
7. Effects of surfactants on the properties of PLGA nanoparticles.
Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
[TBL] [Abstract][Full Text] [Related]
8. Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis.
Platel A; Carpentier R; Becart E; Mordacq G; Betbeder D; Nesslany F
J Appl Toxicol; 2016 Mar; 36(3):434-44. PubMed ID: 26487569
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
[TBL] [Abstract][Full Text] [Related]
10. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
11. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.
Lai P; Daear W; Löbenberg R; Prenner EJ
Colloids Surf B Biointerfaces; 2014 Jun; 118():154-63. PubMed ID: 24769392
[TBL] [Abstract][Full Text] [Related]
12. Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel.
Bansal A; Wu X; Olson V; D'Souza MJ
Int J Pharm; 2018 Jul; 545(1-2):318-328. PubMed ID: 29746999
[TBL] [Abstract][Full Text] [Related]
13. Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment.
Reis CP; Martinho N; Rosado C; Fernandes AS; Roberto A
Drug Dev Ind Pharm; 2014 Mar; 40(3):409-17. PubMed ID: 23480566
[TBL] [Abstract][Full Text] [Related]
14. Size influences the cytotoxicity of poly (lactic-co-glycolic acid) (PLGA) and titanium dioxide (TiO(2)) nanoparticles.
Xiong S; George S; Yu H; Damoiseaux R; France B; Ng KW; Loo JS
Arch Toxicol; 2013 Jun; 87(6):1075-86. PubMed ID: 22983807
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
Vandervoort J; Ludwig A
Int J Pharm; 2002 May; 238(1-2):77-92. PubMed ID: 11996812
[TBL] [Abstract][Full Text] [Related]
16. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
17. Curdlan-Conjugated PLGA Nanoparticles Possess Macrophage Stimulant Activity and Drug Delivery Capabilities.
Tukulula M; Hayeshi R; Fonteh P; Meyer D; Ndamase A; Madziva MT; Khumalo V; Labuschagne P; Naicker B; Swai H; Dube A
Pharm Res; 2015 Aug; 32(8):2713-26. PubMed ID: 25724161
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days.
Navarro SM; Morgan TW; Astete CE; Stout RW; Coulon D; Mottram P; Sabliov CM
Nanomedicine (Lond); 2016 Jul; 11(13):1653-69. PubMed ID: 27347781
[TBL] [Abstract][Full Text] [Related]
19. Potential avoidance of adverse analgesic effects using a biologically "smart" hydrogel capable of controlled bupivacaine release.
Taraballi F; Minardi S; Corradetti B; Yazdi IK; Balliano MA; Van Eps JL; Allegri M; Tasciotti E
J Pharm Sci; 2014 Nov; 103(11):3724-3732. PubMed ID: 25266282
[TBL] [Abstract][Full Text] [Related]
20. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
